Daniel Sadreyev

Affiliations
  • Center for Regenerative Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA.

Publications (1)

Deferasirox, an iron chelator, impacts myeloid differentiation by modulating NF-kB activity via mitochondrial ROS.

British journal of haematology
Avec: Nathan E Jeffries , Daniel Sadreyev , Elizabeth C Trull , Kashish Chetal , Emma E Yvanovich , Michael K Mansour , Ruslan I Sadreyev , David B Sykes

Réseau de co-auteurs

Nathan E Jeffries 1 collaboration
Elizabeth C Trull 1 collaboration
Kashish Chetal 1 collaboration
Emma E Yvanovich 1 collaboration
Michael K Mansour 1 collaboration
Ruslan I Sadreyev 1 collaboration
David B Sykes 1 collaboration